Skip to main content

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Volume 7, Number 2, June 2007


The Role and Potential Therapeutical Applications of Antimicrobial Proteins in Infectious and Inflammatory Diseases
pp. 75-82(8)
Authors: Harder, Jurgen; Glaser, Regine; Schroder, Jens-Michael


Novel Therapeutic Targets for Diabetic Nephropathy
pp. 83-92(10)
Authors: Fukami, K.; Yamagishi, S.; Ueda, S.; Okuda, S.


Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
pp. 99-109(11)
Authors: Gross, G.; Margalit, A.


Free Content CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication
pp. 111-123(13)
Authors: Singh, Udai P.; Venkataraman, Chandrasekar; Singh, Rajesh; Lillard, James W.


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more